Increasing Prevalence of Cardiovascular Diseases to Augment the Natural Biomaterials Market Growth

 

Natural Biomaterials Market

Biomaterials can be classified into two main groups, such as natural and synthetic biomaterials. Natural biomaterial can be any material taken from plants or animals and can be used to augment, replace, or repair body tissues and organs. Each of these types has given rise to applications in specialty areas, ranging from neurology to plastic surgery. Natural biomaterials offer various advantages over synthetic biomaterials. Therefore, these biomaterials are usually applied in the repair or replacement of damaged human tissues and organs.

Market Dynamics:

Increasing prevalence of cardiovascular diseases, cancer, rheumatoid arthritis, osteoarthritis, and sports injuries is expected to propel the growth of the natural biomaterials market. For instance, chronic diseases such as cancer and heart disease are the leading causes of death and disability in the United States, according to the Centers for Disease Control and Prevention (CDC). Moreover, according to Johns Hopkins Medicine, in the U.S., more than 3.5 million children ages 14 and younger get hurt annually playing sports or participating in recreational activities. Almost one-third of all injuries incurred in childhood are sports-related injuries.

Rising bio-based research, increasing conferences of biomaterials, high healthcare expenditure, and developed healthcare infrastructure are some of the factors expected to fuel the growth of the natural biomaterials market. Furthermore, increasing research and development activities are also expected to augment the growth of the natural biomaterials market. For instance, researchers from the Indian Institute of Science are working towards advances in the fields of biomaterials and nanotechnology that could lead to big breakthroughs in the fight against dangerous viruses, such as coronavirus, by making hospital beds or doorknobs that could fight and kill viruses on their own.

America and the Asia Pacific is expected to witness substantial growth in the natural biomaterials market due to the increasing demand for natural biomaterials for wound healing applications and increasing number of plastic surgeries in these regions. For instance, in 2018, more than 17.7 million surgical and minimally-invasive cosmetic procedures performed in the United States, according to the American Society of Plastic Surgeons (ASPS).

Competitive Analysis:

Major players operating in the natural biomaterials market are Medtronic, Inc., Botiss Biomaterials GmbH, Corbion N.V., Royal DSM, Invibio Ltd., Biomet, Inc., BASF SE, and Mimetis Biomaterials.

In February 2021, W. L. Gore & Associates announced that GORE SYNECOR Intraperitoneal Biomaterial is now available in Europe, Middle East, and South Africa. The device was designed to address unmet needs in complex hernia repair, providing rapid vascularity3 and permanent strength with a low profile for single, effective hernia repair.

In January 2021, Essent Biologics announced its launch as a new venture to meet the growing need for biomaterials and data to the regenerative medicine research community.


Comments

Popular posts from this blog

Fitness Equipment Market is doing warm-ups to pull growth-rich opportunities from the growing obesity rates accompanied by the sedentary lifestyles

The market for ureteral stents would benefit from the rising prevalence of urological diseases

The North America Vision Care Market Is Driven by the Increasing Prevalence of Eye Diseases in this Region